6 April 2022
Cube Labs, the venture builder in healthcare in Italy, convened the inaugural meeting of its international Strategic Advisory Board (SAB) in Milan, Italy on 24-25 March 2022.
The meeting brought together for the first time the whole panel of Cube Labs advisors – a distinguished group of experts in life science industry, business and innovation – to support Cube Labs in its path to technology development, on business strategy and the longer-term strategy of Cube Labs in Europe and beyond.
The meeting was chaired by Yossi Bornstein, the Founder and CEO of Shizim Group, a leading life science holding company based in Israel. The participants included Adam Broncel, MD, PhD, Founder of Poland Ventures and Co-founder of Biomed Venture Capital fund; Slawomir Chomik, MD, PhD, Managing Partner of Medical Research Center and MRC Ventures in Poland; Jeremy Curnock Cook, a veteran in life sciences industry and Chairman of International Bioscience Managers; Yaron Itzhari, high tech industry leader and former CEO of Medtronic in Israel; Adina Krausz, CEO of Innosource, advisor to startups, corporates and venture capitalists; Pierre Morgon, CEO of MRGN Advisors with many years of experience in global life science industry; Mikael Oerum, Founder of Ventac Partners with executive and strategic experience in the pharmaceutical, biotech and finance sectors; Banu Onaral, H. H. Sun Professor of Biomedical Engineering and Electrical Engineering at Drexel University in Philadelphia, and leader in Global Innovation Partnerships; Ferran Prat, a business angel in healthcare with many years of experience in diagnostics and pharmaceuticals; Wee Meng Thoo, investor and fund manager with former leadership roles in global technology firms; and Fintan Walton, PhD, CEO and Founder of PharmaVentures, a leading advisory on partnering, M&A and strategic alliances.
Over the course of the two-day meeting, portfolio management strategy and business strategy were assessed within the context of Cube Labs’ differentiators and long-term objectives.
The SAB will reconvene in six months to evaluate the evolution and advancement of Cube Labs.
About Cube Labs
Cube Labs is the first venture builder in the healthcare technology space in Italy, designed to address the gap between the excellent local academic science and the commercially promising life sciences market. Cube Labs builds new companies from promising R&D and enables innovation in order to transform pioneering science into healthcare solutions. Through its international network, Cube Labs works together with communities interested in innovation to transform outcomes for patients and accelerate the world’s transition to optimal health.